Exendin-4 and exercise improve hepatic glucose homeostasis by promoting insulin signaling in diabetic rats

Metabolism: Clinical and Experimental

Volumn 59, Issue 1, 2010, Pages 123-133

  Park, Sunmin ^a   Hong, Sang Mee ^a   Ahn, Il Sung ^a  

^a Institute of Basic Sciences   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; EXENDIN 4; GLUCAGON; INSULIN; INSULIN RECEPTOR SUBSTRATE 2; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP);

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DRUG MECHANISM; GLUCAGON BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HYPERINSULINEMIA; HYPOTHALAMUS; LIPID DIET; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; TREADMILL EXERCISE;

ANIMALS; BASE SEQUENCE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DNA PRIMERS; ENERGY INTAKE; GLUCAGON; GLUCOSE; HOMEOSTASIS; INSULIN; LIVER; MALE; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 72049099836     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.06.026     Document Type: Article

References (40)

1. DeFronzo R.A., and Ferrannini E. Regulation of intermediary metabolism during fasting and feeding. In: DeGroot L.J., and Jameson J.L. (Eds). Endocrinology (2001), W.B. Saunders Co, Philadelphia 737-755
2. Taylor S.I. Deconstructing type 2 diabetes. Cell 97 (1999) 9-12
3. Kim J.K., Kim Y.J., Fillmore J.J., et al. Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 108 (2001) 437-446
4. Rutter G.A. Diabetes: the importance of the liver. Curr Biol 10 (2000) R736-R738
5. Park S.H., Kim B.I., Yun J.W., et al. Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men. J Gastroenterol Hepatol 19 (2004) 694-698
6. Brubaker P.L., and Drucker D.J. Glucagon-like peptides regulate cell proliferation and apoptosis in the pancreas, gut and central nervous system. Endocrinology 145 (2004) 2653-2659
7. Aziz A., and Anderson G.H. Exendin-4, a GLP-1 receptor agonist, interacts with proteins and their products of digestion to suppress food intake in rats. J Nutri 133 (2003) 2326-2330
8. Ma X., Bruning J., and Ashcroft F.M. Glucagon-like peptide 1 stimulates hypothalamic proopiomelanocortin neurons. J Neurosci 27 (2007) 7125-7129
9. Drucker D.J. Biological actions and therapeutic potential of the glucagon-like peptides. Gastroenterology 122 (2002) 531-544
10. Drucker D.J. Enhancing incretin action for the treatment of type 2 diabetes. Diabetes Care 26 (2003) 2929-2940
11. Hansotia T., and Drucker D.J. GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice. Regul Peptides 128 (2005) 125-134
12. Movassat J., Beattie G.M., Lopez A.D., and Hayek A. Exendin-4 up-regulates expression of PDX-1 and hastens differentiation and maturation of human fetal pancreatic cells. J Clin Endocri Metab 87 (2002) 4775-4781
13. Lee Y.S., Shin S., Shigihara T., et al. Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis. Diabetes 56 (2007) 1671-1679
14. Ding X., Saxena N.K., Lin S., Gupta N.A., and Anania F.A. Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice. Hepatology 43 (2006) 173-181
15. Perrini S., Henriksson J., Zierath J.R., and Widegren I.U. Exercise-induced protein kinase C isoform-specific activation in human skeletal muscle. Diabetes 53 (2004) 21-24
16. Heled Y., Shapiro Y., Shani Y., et al. Physical exercise enhances hepatic insulin signaling and inhibits phosphoenolpyruvate carboxykinase activity in diabetes-prone Psammomys obesus. Metabolism 53 (2004) 836-841
17. Chang S.P., Chen Y.H., Chang W.C., Liu I.M., and Cheng J.T. Merit of physical exercise to reverse the higher gene expression of hepatic phosphoenolpyruvate carboxykinase in obese Zucker rats. Life Sci 79 (2006) 240-246
18. Park S., Jang J.S., Jun D.W., and Hong S.M. Exercise enhances insulin and leptin signaling in the cerebral cortex and hypothalamus during dexamethasone-induced stress in diabetic rats. Neuroendocrinology 82 (2005) 282-293
19. Flores M.B., Fernandes M.F., Ropelle E.R., et al. Exercise improves insulin and leptin sensitivity in hypothalamus of Wistar rats. Diabetes 55 (2006) 2554-2561
20. Hosokawa Y.A., Hosokawa H., Chen C., and Leahy J.L. Mechanism of impaired glucose-potentiated insulin secretion in diabetic 90% pancreatectomy rats. Study using glucagons like peptide-1 (7-37). J Clin Invest 97 (1996) 180-186
21. Kwon D.Y., Jang J.S., Hong S.M., et al. Long-term consumption of fermented soybean-derived Chungkookjang enhances insulinotropic action unlike soybeans in 90% pancreatectomized diabetic rats. Eur J Nutr 46 (2007) 44-52
22. Choi S.B., Jang J.S., Hong S.M., Jun D.W., and Park S. Exercise and dexamethasone oppositely modulate β-cell function and survival via independent pathways in 90% pancreatectomized rats. J Endocrinol 190 (2006) 471-482
23. Sebokova E., Klimes I., Moss R., et al. Muscle GLUT 4 protein levels and impaired triglyceride metabolism in streptozotocin diabetic rats. Effect of a high sucrose diet and fish oil supplementation. Ann NY Acad Sci 683 (1993) 218-227
24. Samuel V.T., Choi C.S., Phillips T.G., et al. Targeting foxo1 in mice using antisense oligonucleotide improves hepatic and peripheral insulin action. Diabetes 55 (2006) 2042-2050
25. Short M.K., Clouthier D.E., Schaefer I.M., et al. Tissue-specific, developmental, hormonal, and dietary regulation of rat phosphoenolpyruvate carboxykinase-human growth hormone fusion genes in transgenic mice. Mol Cell Biol 12 (1992) 1007-1020
26. Minokoshi Y., Kim Y.B., Peroni O.D., et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415 (2002) 339-343
27. Jakobsen S.N., Hardie D.G., Morrice N., and Tornqvist H.E. 5′-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside. J Biol Chem 276 (2001) 46912-46916
28. Obici S., Zhang B.B., Karkanias G., and Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 8 (2002) 1376-1382
29. Okamoto H., Obici S., Accili D., and Rossetti L. Restoration of liver insulin signaling in Insr knockout mice fails to normalize hepatic insulin action. J Clin Invest 115 (2005) 1314-1322
30. Barthel A., and Schmoll D. Novel concepts in insulin regulation of hepatic gluconeogenesis. Am J Physiol-Endocrin Metab 285 (2003) E685-E692
31. Park S., Hong S.M., and Sung S.R. Exendin-4 and exercise promotes beta-cell function and mass through IRS2 induction in islets of diabetic rats. Life Sci 82 (2008) 503-511
32. Ayala J.E., Bracy D.P., James F.D., Julien B.M., Wasserman D.H., and Drucker D.J. The glucagon-like peptide-1 receptor regulates endogenous glucose production and muscle glucose uptake independent of its incretin action. Endocrinology 150 (2009) 1155-1164
33. Holst J.J. The physiology of glucagon-like peptide 1. Physiol Rev 87 (2007) 1409-1439
34. Liu Z., and Habener J.F. Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation. J Biol Chem 283 (2008) 8723-8735
35. Park S., Dong X., Fisher T.L., et al. Exendin-4 promotes IRS2 signaling to mediate pancreatic beta-cell growth and function. J Biol Chem 281 (2006) 1159-1168
36. Canettieri G., Koo S.H., Berdeaux R., et al. Dual role of the coactivator TORC2 in modulating hepatic glucose output and insulin signaling. Cell Metab 2 (2005) 331-338
37. Jhala U.S., Canettieri G., Screaton R.A., et al. cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Gene Dev 17 (2003) 1575-1580
38. Li L., Yang G., Li Q., et al. Exenatide prevents fat-induced insulin resistance and raises adiponectin expression and plasma levels. Diabetes Obes Metab 10 (2008) 921-930
39. Valverde A.M., Burks D.J., Fabregat I., et al. Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes. Diabetes 52 (2003) 2239-2248
40. Dong X., Park S., Lin X., Copps K., Yi X., and White M.F. Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth. J Clin Invest 116 (2006) 101-114